Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT05269381

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

This phase I/II trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients…

United States132 participantsStarted 2022-03-31

Treatment: Cyclophosphamide, Neoantigen Peptide Vaccine

All recent trials (2 shown)

Active — Not RecruitingPhase 3

NCT03712605

Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial

This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that…

United States280 participantsStarted 2018-11-15

Treatment: Best Practice, Biospecimen Collection